1. Home
  2. Live Updates
  3. In atypical Big Pharma-VC pact, Gilead secures $210M from Abingworth to fund Trodelvy trials : vimarsana.com

In atypical Big Pharma-VC pact, Gilead secures $210M from Abingworth to fund Trodelvy trials : vimarsana.com

In atypical Big Pharma-VC pact, Gilead secures $210M from Abingworth to fund Trodelvy trials

In atypical Big Pharma-VC pact, Gilead secures $210M from Abingworth to fund Trodelvy trials

fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

California , United States , Carlyle Abingworth , Merck Keytruda , Merdad Parsey , Abingworth Carlyle , Gilead Sciences , Johnson , Chief Medical Officer Merdad Parsey , Fierce Pharma , Launch Therapeutics , Big Pharma ,